Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Certolizumab pegol
Cimzia
Not routinely available
SMC (1155/16)
09/05/2016
Indication
Treatment of severe, active and progressive RA in adults not previously treated with MTX or other DMARDs.
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
200mg solution for injection
Comments
None
Link to Advice
Advice Published
09/05/2016
SMC Submission Type
Non submission
SMC Status
Not recommended